Tag: ADA 2026
Eli Lilly Reports Safety Data for Next-Generation Obesity Drug Retatrutide
Eli Lilly presented new safety data for retatrutide, its triple-hormone obesity drug, at the 2026 American Diabetes Association meeting. The…
Submit Your Paper to GMJ
No APC until January 2027.